Page last updated: 2024-09-02

ecteinascidin 743 and Cancer of Head

ecteinascidin 743 has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kawai, A; Kondo, T; Nakatani, F; Noguchi, R; Ohtori, S; Ono, T; Sei, A; Sin, Y; Sugaya, J; Takeshita, F; Tsuchiya, R; Yoshida, A; Yoshimatsu, Y	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Cancer of Head

Article	Year
Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma. Human cell, 2021, Volume: 34, Issue:5 Topics: Adult; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Dactinomycin; Depsipeptides; Gene Fusion; Head and Neck Neoplasms; Humans; Male; Muscle Proteins; Mutation; MyoD Protein; Nuclear Receptor Coactivator 2; Rhabdomyosarcoma; Sarcoma; Trabectedin; Transcription Factors	2021

Article

Year

Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.

Human cell, 2021, Volume: 34, Issue:5

Topics: Adult; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Dactinomycin; Depsipeptides; Gene Fusion; Head and Neck Neoplasms; Humans; Male; Muscle Proteins; Mutation; MyoD Protein; Nuclear Receptor Coactivator 2; Rhabdomyosarcoma; Sarcoma; Trabectedin; Transcription Factors

2021